Amoéba extends its agreement with Koppert to arboriculture in 19 EU countries
Amoéba's biofungicide, already distributed by Koppert for vines and vegetable crops, is to be extended to a third market: arboriculture, in 19 European Union countries.
According to the press release published on 16 November 2026, this segment represents 10% of the value of the European fungicide market. It ranks fourth, behind wheat, vines and potatoes.
A third component after vines and vegetables, extended until 2031
Amoéba and the Dutch company Koppert have announced the extension of their distribution agreement to arboriculture. This decision follows an initial phase of co-development and preliminary trials. It comes after the extension, announced on 23 July 2026, of the initial agreement covering vines and vegetable crops until June 2031.
The new agreement targets apples, pears, apricots, quinces, nashi pears, crab apples and medlars. The geographic scope notably covers France, Germany, Italy, Spain, the Netherlands and Poland.
It builds on the recent commercial launch of the Tiagan products for vines and Yazu for vegetable crops, both developed using Amoéba's Axpera technology.
Over 90% efficacy in combined trials, new campaign in 2027
The first joint trial campaign was carried out in 2026 on apple trees in 5 European countries. It focused on apple scab and powdery mildew, the two major diseases of the apple tree. Conducted in combination with conventional fungicides, these trials demonstrated an efficacy of over 90% against these two diseases.
A new trial campaign is planned for 2027 on apples and pears, in order to confirm the performance measured and to test new programmes with arboriculturists. Commercialisation of the product is planned for 2029, subject to obtaining the usual regulatory approvals.
Martin Koppert, product director at Koppert, stated that his group will continue evaluating Axpera “under real growing conditions.” Jean-Marc Petat, managing director of Green for Agro, a subsidiary of Amoéba dedicated to biosolutions, stated: “we will continue the trials with arboriculturists.”
Nearly 600,000 hectares of orchards and a target of 40% of the area
The agreement covers nearly 600,000 hectares of orchards, including 320,000 hectares of apple trees and 80,000 hectares of pear trees. According to the press release, producers generally spend between €1,000 and €1,500 per hectare per year on protecting their crops against fungal diseases.
The two partners aim to eventually protect approximately 40% of the area. Amoéba indicates that this agreement reinforces its target of €40 million in revenue by 2030.
On the financial side, the company announced on 27 October 2026 the successful completion of a €9.7 million capital increase, with settlement and delivery scheduled for 29 October. It then estimated that its financing was secured until September 2027, that is, before the commercialisation date targeted for arboriculture.